Epitel

About

Epitel, Inc. is a digital health company based in Salt Lake City, Utah, dedicated to enhancing brain health solutions through innovative wearable EEG monitoring technology. Founded in 2008 by Mark Lehmkuhle, PhD, the company aims to improve seizure detection and monitoring, particularly for epilepsy and related conditions. The flagship product, the REMI™ Remote EEG Monitoring System, is a wearable, wireless EEG sensor that utilizes proprietary cloud-based software. This system, which received FDA clearance in 2021, allows for remote electrographic seizure detection, making EEG monitoring more accessible and reliable. Epitel's technology is designed for use in hospital emergency rooms and critical care units, with plans to expand into outpatient settings for epilepsy patients. The company has secured over $20 million in funding to support its commercialization and development efforts. Epitel's leadership team brings extensive experience in medical devices, neural engineering, and regulatory affairs, positioning the company to effectively address the needs of patients and healthcare providers in the epilepsy market.